Jonathan Curtain

Jonathan joined Ergomed as Deputy Chief Financial Officer in November 2022, bringing with him extensive life sciences industry experience, having spent 13 years with ICON plc, a leading global CRO business listed on NASDAQ with a market capitalisation of $19 billion.

Most recently, he was the Senior Vice President of Corporate and Commercial Finance, where he had a broad range of responsibilities including financial reporting, acquisitions and post-acquisition integration, debt and equity fundraising, treasury, commercial finance and overall financial management.

During his time with ICON, he also led the Investor Relations function and played a key role in transactions worth over $13.5 billion including most recently the $12 billion acquisition by ICON of PRA Health Sciences Inc. Jonathan is a Fellow of the Institute of Chartered Accountants with over 20 years’ experience since receiving his ACA qualification at KPMG.